FDA approves nivolumab and ipilimumab for unresectable malignant pleural mesothelioma
FDA approves nivolumab and ipilimumab for unresectable malignant pleural mesothelioma
Source: FDA Center for Drug Evaluation and Research - What's New - Category: Drugs & Pharmacology Authors: FDA Source Type: news